I agree that the guidelines are difficult to understand when you just read through them. I think that the period of consultation that was undertaken by the price review board really enabled people who were involved in those consultations or who were observing them to understand what the impact of the guidelines could possibly be and what the rationale was behind the guidelines. I think that the price review board did its due diligence to help people understand what the guidelines are intended to do.
The pharmaceutical industry, including the companies that you just referred to, have entire legal departments at their disposal to help them understand what obligations they would be required to undertake if they complied with the guidelines.